Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Arthritis and Rheumatism|September 29, 2011
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reductionDebby den Uyl, Daniel H van Raalte, Michael T Nurmohamed, et al.
The Journal of Rheumatology|December 4, 2009
Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitisMike J L Peters, Izhar C van Eijk, Yvo M Smulders, et al.
Annals of the Rheumatic Diseases|February 16, 2007
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisGeertje M Bartelds, Carla A Wijbrandts, Michael T Nurmohamed, et al.
Clinical and Experimental Rheumatology|April 4, 2019
Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic dataJill Ruwaard, Anneke F Marsman, Michael T Nurmohamed, et al.
Annals of the Rheumatic Diseases|October 5, 2013
Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitisAlper M van Sijl, Izhar C van Eijk, Mike J L Peters, et al.
BMC Musculoskeletal Disorders|April 18, 2015
Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluationSjoerd C Heslinga, Inge A Van den Oever, Alper M Van Sijl, et al.
Rheumatology (Oxford, England)|September 17, 2020
Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritisIttai B Muller, Marry Lin, Willem F Lems, et al.
Seminars in Arthritis and Rheumatism|October 5, 2010
Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysisAlper M van Sijl, Mike J Peters, Dirk K Knol, et al.
Annals of the Rheumatic Diseases|November 12, 2010
The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanerceptAnna Jamnitski, Geertje M Bartelds, Michael T Nurmohamed, et al.
The Journal of Rheumatology|January 17, 2015
Objective evaluation of physical functioning after tumor necrosis factor inhibitory therapy in patients with ankylosing spondylitis: a selection of 3 feasible performance-based testsSalima F E van Weely, Joost Dekker, Martijn P M Steultjens, et al.
Pageof 18